During the final reporting period, the EURAMED rocc-n-roll project made substantial strides in medical radiation research. It systematically analysed gaps and research needs, incorporating insights from sources like SAMIRA, SMER reports, PRISMAP, and MEDICIS, thereby expanding the research topics encompassed by the Strategic Research Agenda (SRA). Alignment with regulatory requirements was ensured by gathering input from regulators.
Consensus was achieved on research priorities for disease-dependent ionizing radiation applications, spanning oncology, neurovascular, cardiovascular diseases, pediatrics, pregnant women, and chronic diseases, including screening program optimization. Patient perspectives played a central role throughout the project, with a dedicated patient panel providing valuable feedback.
The project explored European funding programs, identifying common interests and synergies to optimise research funding opportunities. Criteria for identifying Centers of Excellence in ionizing radiation research were established, promoting collaboration. Investigation into the potential of AI and electronic patient records in ionizing radiation research addressed ethical considerations.
A comprehensive framework streamlined translational challenges, facilitating the progression of research to industrial application, product development, and clinical use. Sustainability concerns in medical radiation protection were identified via a survey, emphasising long-term ethical and environmental considerations.
The project conducted exemplary training events based on a methodological framework and a guidance document for radiation protection education and training, ensuring the competence of professionals in the field.
The project's core achievement was the development of the EURAMED rocc-n-roll Strategic Research Agenda, the roadmap, and an interlink document. These guides will continue to shape future research, fostering collaboration and innovation in medical radiation protection.
